Clinical trials
Recruiting Urinary Bladder Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daiichi Sankyo | 2 |
| Eli Lilly and Company | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Charite University, Berlin, Germany | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fore Biotherapeutics | 1 |
| Guardant Health, Inc. | 1 |
| Ludwig-Maximilians - University of Munich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 17 |
| Esophageal Neoplasms | 5 |
| Head and Neck Neoplasms | 4 |
| Non-Muscle Invasive Bladder Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Transitional Cell | 3 |
| Melanoma | 3 |
| Pancreatic Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Rectal Neoplasms | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.